Highlights and News

Bronchiectasis - A Clinical Review | NEJM - nejm.org
Bronchiectasis - A Clinical Review | NEJM  nejm.org
Diabetes brand awareness in the doldrums despite plowing big bucks into ad campaigns - FiercePharma
Diabetes brand awareness in the doldrums despite plowing big bucks into ad campaigns  FiercePharma
Autoinjectors Market Size is projected to reach USD 4.61 Billion by 2030, growing at a CAGR of 18.23%: Straits Research - Yahoo Finance
Autoinjectors Market Size is projected to reach USD 4.61 Billion by 2030, growing at a CAGR of 18.23%: Straits Research  Yahoo Finance
AbbVie keeps its foot down with the 'extreme' Rinvoq TV ad push - FiercePharma
AbbVie keeps its foot down with the 'extreme' Rinvoq TV ad push  FiercePharma
Frailty may be reversible for some people with rheumatoid arthritis - Medical Xpress
Frailty may be reversible for some people with rheumatoid arthritis  Medical Xpress
Highest-risk patients eligible for new COVID-19 treatments: a guide for patients - GOV.UK
Highest-risk patients eligible for new COVID-19 treatments: a guide for patients  GOV.UK
Rheumatoid arthritis in hands: Stage 1, progression, and more - Medical News Today
Rheumatoid arthritis in hands: Stage 1, progression, and more  Medical News Today
Frailty common in rheumatoid arthritis, predicts mortality, hospitalization - Healio
Frailty common in rheumatoid arthritis, predicts mortality, hospitalization  Healio
All or something: Experts debate LDA vs. remission as a target in rheumatoid arthritis - Healio
All or something: Experts debate LDA vs. remission as a target in rheumatoid arthritis  Healio
Defining the highest-risk clinical subgroups upon community infection with SARS-CoV-2 when considering the use of neutralising monoclonal antibodies (nMABs) and antiviral drugs: independent advisory group report - GOV.UK
Defining the highest-risk clinical subgroups upon community infection with SARS-CoV-2 when considering the use of neutralising monoclonal antibodies (nMABs) and antiviral drugs: independent advisory group report  GOV.UK
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial - The Lancet
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial  The Lancet
COVID-19: guidance for people whose immune system means they are at higher risk - GOV.UK
COVID-19: guidance for people whose immune system means they are at higher risk  GOV.UK
Strategies for Successfully Treating Rheumatoid Arthritis - Rheumatology Advisor
Strategies for Successfully Treating Rheumatoid Arthritis  Rheumatology Advisor
Midfoot arthritis: Symptoms, causes, and treatment - Medical News Today
Midfoot arthritis: Symptoms, causes, and treatment  Medical News Today
Covid-19: surging demand for some arthritis drugs - The BMJ
Covid-19: surging demand for some arthritis drugs  The BMJ
Rheumatoid arthritis and the eyes: Impact and symptoms - Medical News Today
Rheumatoid arthritis and the eyes: Impact and symptoms  Medical News Today
Is arthritis making your life a misery? Try a workout... or a chat! - Daily Mail
Is arthritis making your life a misery? Try a workout... or a chat!  Daily Mail
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform - The Lancet
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform  The Lancet
Rheumatoid Arthritis Differential Diagnosis - Verywell Health
Rheumatoid Arthritis Differential Diagnosis  Verywell Health
US anti-abortion laws may restrict access to vital drug for autoimmune diseases, patient groups warn - The BMJ
US anti-abortion laws may restrict access to vital drug for autoimmune diseases, patient groups warn  The BMJ
Understanding hip arthritis: risk factors, symptoms and treatments - Spire Healthcare
Understanding hip arthritis: risk factors, symptoms and treatments  Spire Healthcare
400,000 NHS patients suffering from psoriatic arthritis to benefit from new daily pill rollout - Daily Mail
400,000 NHS patients suffering from psoriatic arthritis to benefit from new daily pill rollout  Daily Mail
Rheumatoid Arthritis Symptoms, Signs & Causes - Spire Healthcare
Rheumatoid Arthritis Symptoms, Signs & Causes  Spire Healthcare
Hydroxychloroquine, chloroquine: increased risk of cardiovascular events when used with macrolide antibiotics; reminder of psychiatric reactions - GOV.UK
Hydroxychloroquine, chloroquine: increased risk of cardiovascular events when used with macrolide antibiotics; reminder of psychiatric reactions  GOV.UK
Integrated single cell and spatial transcriptomics reveal autoreactive differentiated B cells in joints of early rheumatoid arthritis | Scientific Reports - Nature.com
Integrated single cell and spatial transcriptomics reveal autoreactive differentiated B cells in joints of early rheumatoid arthritis | Scientific Reports  Nature.com
Exercise and weight-loss are key to combating crippling arthritis, health watchdog says - Daily Mail
Exercise and weight-loss are key to combating crippling arthritis, health watchdog says  Daily Mail
Dame Sheila Hancock receives biologic drug injections to manage rheumatoid arthritis pain - Daily Mail
Dame Sheila Hancock receives biologic drug injections to manage rheumatoid arthritis pain  Daily Mail
New breakthrough in the treatment of rheumatoid arthritis - University of Birmingham
New breakthrough in the treatment of rheumatoid arthritis  University of Birmingham
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis | NEJM - nejm.org
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis | NEJM  nejm.org
Hydroxychloroquine or chloroquine, in combination with macrolide antibiotics: review of epidemiological data for cardiovascular safety - GOV.UK
Hydroxychloroquine or chloroquine, in combination with macrolide antibiotics: review of epidemiological data for cardiovascular safety  GOV.UK
Steroids for Rheumatic Disease and Regional Pain Disorders - PracticalPainManagement.com
Steroids for Rheumatic Disease and Regional Pain Disorders  PracticalPainManagement.com
Can arthritis be reversed? - Medical News Today
Can arthritis be reversed?  Medical News Today
Heal n Soothe Reviews -How Does it Work For Chronic Pain-Get Free Bottle Today - Outlook India
Heal n Soothe Reviews -How Does it Work For Chronic Pain-Get Free Bottle Today  Outlook India
What Runners Should Know About Running and Rheumatoid Arthritis - runnersworld.com
What Runners Should Know About Running and Rheumatoid Arthritis  runnersworld.com
Diseases that mimic polymyalgia rheumatica (PMR) - Medical News Today
Diseases that mimic polymyalgia rheumatica (PMR)  Medical News Today
Natural treatments for osteoarthritis - Medical News Today
Natural treatments for osteoarthritis  Medical News Today
X-Rays and Medical Imaging for Arthritis Diagnosis - Health Central
X-Rays and Medical Imaging for Arthritis Diagnosis  Health Central
Rheumatologist for psoriatic arthritis: How they can help - Medical News Today
Rheumatologist for psoriatic arthritis: How they can help  Medical News Today
RA: Still a Clinical Diagnosis | MedPage Today - Medpage Today
RA: Still a Clinical Diagnosis | MedPage Today  Medpage Today
"There isn't anything like it in the UK" - University of Cambridge news
"There isn't anything like it in the UK"  University of Cambridge news
Rheumatology - University College London Hospitals
Rheumatology  University College London Hospitals
'Milestone' as NICE recommends biologics in moderate rheumatoid arthritis for the first time - The Pharmaceutical Journal
'Milestone' as NICE recommends biologics in moderate rheumatoid arthritis for the first time  The Pharmaceutical Journal
Rheumatoid Arthritis Progression: Tests That Track Activity - Verywell Health
Rheumatoid Arthritis Progression: Tests That Track Activity  Verywell Health
The Complete Guide To Becoming A Rheumatology Doctor - The BMJ
The Complete Guide To Becoming A Rheumatology Doctor  The BMJ
Fatigue common even with early rheumatoid arthritis - Medical Xpress
Fatigue common even with early rheumatoid arthritis  Medical Xpress
New drugs for psoriatic arthritis: Latest medications - Medical News Today
New drugs for psoriatic arthritis: Latest medications  Medical News Today
Research reveals that anti-TNF drug reverses Dupuytren's disease - Open Access Government
Research reveals that anti-TNF drug reverses Dupuytren's disease  Open Access Government
Hip pain at night (sleeping): causes and symptoms - Spire Healthcare
Hip pain at night (sleeping): causes and symptoms  Spire Healthcare
Osteoarthritis in the foot: Symptoms and how to manage it - Medical News Today
Osteoarthritis in the foot: Symptoms and how to manage it  Medical News Today
Rheumatoid arthritis in the hip: Symptoms and management - Medical News Today
Rheumatoid arthritis in the hip: Symptoms and management  Medical News Today

Articles/peer reviewed publications and
Lay Summaries

  • B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure.
    Rivellese F, Humby F, Bugatti S, Fossati-Jimack L, Rizvi H, Lucchesi D, Lliso-Ribera G, Nerviani A, Hands RE, Giorli G, Frias B, Thorborn G, Jaworska E, John C, Goldmann K, Lewis MJ, Manzo A, Bombardieri M, Pitzalis C; PEAC- R4RA investigators. 
    Arthritis Rheumatol. 2019 Nov 29.
    https://doi.org/10.1002/art.41184
    See Lay Summary




The R4-RA trial is funded by the MRC-NIHR Efficacy and
Mechanism Evaluation Programme